These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30091380)

  • 21. Continuous inhalation of carbon monoxide induces right ventricle ischemia and dysfunction in rats with hypoxic pulmonary hypertension.
    Gautier M; Antier D; Bonnet P; Le Net JL; Hanton G; Eder V
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1046-52. PubMed ID: 17483237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.
    Michelakis ED; McMurtry MS; Wu XC; Dyck JR; Moudgil R; Hopkins TA; Lopaschuk GD; Puttagunta L; Waite R; Archer SL
    Circulation; 2002 Jan; 105(2):244-50. PubMed ID: 11790708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats.
    Pham H; Vottier G; Pansiot J; Duong-Quy S; Bollen B; Dalous J; Gallego J; Mercier JC; Dinh-Xuan AT; Bonnin P; Charriaut-Marlangue C; Baud O
    Exp Neurol; 2014 Feb; 252():114-23. PubMed ID: 24322053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative effects of calcium channel blockers and L-arginine on chronic intermittent hypoxic pulmonary hypertension in rats].
    Li MR; Chen SC; Ma G
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Dec; 17(6):372-4, 385. PubMed ID: 7712585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats.
    Zhang E; Maruyama J; Yokochi A; Mitani Y; Sawada H; Nishikawa M; Ma N; Maruyama K
    J Anesth; 2015 Oct; 29(5):715-23. PubMed ID: 25931318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genistein attenuates hypoxic pulmonary hypertension via enhanced nitric oxide signaling and the erythropoietin system.
    Kuriyama S; Morio Y; Toba M; Nagaoka T; Takahashi F; Iwakami S; Seyama K; Takahashi K
    Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(11):L996-L1005. PubMed ID: 24705719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor.
    Tang JR; Markham NE; Lin YJ; McMurtry IF; Maxey A; Kinsella JP; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2004 Aug; 287(2):L344-51. PubMed ID: 15064225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
    He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
    Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α.
    Sewing AC; Kantores C; Ivanovska J; Lee AH; Masood A; Jain A; McNamara PJ; Tanswell AK; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(1):L75-87. PubMed ID: 22582114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration.
    Irwin DC; Baek JH; Hassell K; Nuss R; Eigenberger P; Lisk C; Loomis Z; Maltzahn J; Stenmark KR; Nozik-Grayck E; Buehler PW
    Free Radic Biol Med; 2015 May; 82():50-62. PubMed ID: 25656991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic iron overload induces vascular dysfunction in resistance pulmonary arteries associated with right ventricular remodeling in rats.
    Bertoli SR; Marques VB; Rossi EM; Krause M; Carneiro MTWD; Simões MR; Dos Santos L
    Toxicol Lett; 2018 Oct; 295():296-306. PubMed ID: 29990562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats.
    Schwenke DO; Tokudome T; Shirai M; Hosoda H; Horio T; Kishimoto I; Kangawa K
    Endocrinology; 2008 Jan; 149(1):237-44. PubMed ID: 17916633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt5a attenuates hypoxia-induced pulmonary arteriolar remodeling and right ventricular hypertrophy in mice.
    Jin Y; Wang W; Chai S; Liu J; Yang T; Wang J
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1742-51. PubMed ID: 25956683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
    Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P
    Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
    Horstman DJ; Frank DU; Rich GF
    Anesth Analg; 1998 Jan; 86(1):74-81. PubMed ID: 9428855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.
    Steudel W; Scherrer-Crosbie M; Bloch KD; Weimann J; Huang PL; Jones RC; Picard MH; Zapol WM
    J Clin Invest; 1998 Jun; 101(11):2468-77. PubMed ID: 9616218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polydatin attenuates hypoxic pulmonary hypertension and reverses remodeling through protein kinase C mechanisms.
    Miao Q; Shi XP; Ye MX; Zhang J; Miao S; Wang SW; Li B; Jiang XX; Zhang S; Hu N; Li J; Zhang J
    Int J Mol Sci; 2012; 13(6):7776-7787. PubMed ID: 22837726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.